Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms in a Randomized Controlled Trial (RCT)
Oui Therapeutics, Inc.
40 participants
Dec 9, 2025
INTERVENTIONAL
Conditions
Summary
This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD
Comparator designed to match interface of intervention while providing no active treatment.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07316088